Skip to main content
. 2021 Nov 12;22:796. doi: 10.1186/s13063-021-05783-8
Title {1} Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomized non-inferiority trial (ORAL)
Trial registration {2a and 2b}.

ClinicalTrials.gov identifier: NCT04140903, first registered 28.10.2019.

EudraCT number: 2019-002845-39, first registered 03.07.2019

Protocol version {3} 1 Version 1.2 of March 10, 2021
Funding {4} Economic support for all aspects of conducting the trial is provided by the Novo Nordisk Foundation (Grant 0057510)
Author details {5a}

Jacob Bodilsen (Aalborg University Hospital, Denmark)

Henrik Nielsen (Aalborg University Hospital, Denmark)

Matthijs C. Brouwer (Amsterdam UMC, The Netherlands)

Diederik van de Beek (Amsterdam UMC, The Netherlands)

Pierre Tattevin (Rennes University Hospital, France)

Steven Tong (Royal Melbourne Hospital, Australia)

Pontus Naucler (Karolinska, Stockholm, Sweden)

Name and contact information for the trial sponsor {5b}

Henrik Nielsen, Professor

Department of Infectious Diseases, Aalborg University Hospital

Mølleparkvej 4, 9000 Aalborg, Denmark

henrik.nielsen@rn.dk

+ 45 97663920

Role of sponsor {5c} The sponsor (HN) and the steering committee (JB, HN, MCB, DvdB, ST, PN, PT) will be responsible for trial completion, data analysis and interpretation.